1. US Renal Data System: USRDS 2000 Annual Data Report. Bethesda, MD, The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2000.
2.
2. National Kidney Foundation: Kidney Disease Outcomes Quality Initiative (NKF K/DOQI) Clinical practice guidelines for vascular access. Am J Kidney Dis37(Suppll):S137-S181, 2001.
3.
3. Ascer E, Gade P, Hingorani A, et al: Changes in the practice of angioaccess surgery: impact of dialysis outcome and quality initiative recommendations. J Vasc Surg31:84-92, 2000.
4.
4. Silva MB, Hobson RW, Pappas PJ, et al: Vein transposition in the forearm for autogenous hemodialysis access. J Vasc Surg26:981-986, 1997.
5.
5. Fullerton JK, McLafferty RB, Ramsey DE, et al: Pitfalls in achieving the Dialysis Outcome Quality Initiative (DOQI) guidelines for hemodialysis access?Ann Vasc Surg16:613-617, 2002.
6.
6. Berman SS, Gentile AT: Impact of secondary procedures in autogenous arteriovenous fistula maturation and maintenance. J Vasc Surg34:866-871, 2001.
7.
7. Matsuura JH, Rosenthal D, Clark M, et al: Transposed basilic vein versus polytetrafluoroethylene for brachial-axillary arteriovenous fistulas. Am J Surg176:219-221, 1998
8.
8. Coburn MC, Carney WI: Comparison of basilic vein and polytetrafluoroethylene for brachial arteriovenous fistula. J Vasc Surg20:896-904, 1994.
9.
9. Murphy GJ, White SA, Knight AJ, et al: Long-term results of arteriovenous fistulas using transposed autologous basilic vein. Br J Surg87:819-823, 2000.
10.
10. Segal JH, Kayler LK, Henke P, et al: Vascular access outcomes using the transposed basilic vein arteriovenous fistula. Am J Kidney Dis42:151-157, 2003.
11.
11. Gibson KD, Gillen DL, Caps MT, et al: Vascular access survival and incidence of revisions: A comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. J Vasc Surg34:694-700, 2001.
